Evidence map›Paper›PMID 32223892›Full record

ArticleeLife2020

Savita Lochab, Yogendra Singh, Sagar Sengupta, Vinay Kumar Nandicoori

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. New Vistas inCancers · 2025
    Article
  5. Mycobacterium tuberculosis Rv1043c regulates the inflammatory response by inhibiting the phosphorylation of TAK1.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Savita LochabNational Institute of Immunology, New Delhi, India.ORCID 0000-0002-8153-7867
Yogendra SinghDepartment of Zoology, University of Delhi, New Delhi, India.ORCID 0000-0002-3902-4355
Sagar SenguptaNational Institute of Immunology, New Delhi, India.ORCID 0000-0002-6365-1770
Vinay Kumar NandicooriNational Institute of Immunology, New Delhi, India.ORCID 0000-0002-5682-4178
National Institute of Immunology · INUniversity of Delhi · IN

Funding

Department of Biotechnology , Ministry of Science and Technology BT/PR13522/COE/34/27/2015Department of Science and Technology, Ministry of Science and Technology JCB/2018/000013
6 · The paper itself

Abstract

(

Indexed as

DNA Breaks, Double-StrandedHost-Pathogen InteractionsSignal TransductionAdenosine TriphosphatasesAnimalsAtaxia Telangiectasia Mutated ProteinsBacterial ProteinsFemaleHumansLungMaleMembrane Transport ProteinsMiceMice, Inbred BALB CMorpholinesMycobacterium tuberculosis2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-oneAdenosine TriphosphatasesAkt1 protein, mouseAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseBacterial ProteinsMembrane Transport ProteinsMorpholinesProto-Oncogene Proteins c-aktPyronesSecA2 protein, MycobacteriumAktATM kinaseDNA damageinfectious diseasemicrobiologyMycobacterium tuberculosisSecA2secretome

Identifiers

PMID32223892
PMCPMC7162654
OpenAlexW3013534464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.